Citius Pharmaceuticals Inc (CTXR)
0.346
-0.01
(-3.59%)
USD |
NASDAQ |
Nov 04, 16:00
0.346
0.00 (0.00%)
After-Hours: 20:00
Citius Pharmaceuticals Research and Development Expense (TTM): 11.87M for June 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | 11.87M |
| March 31, 2024 | 12.88M |
| December 31, 2023 | 14.00M |
| September 30, 2023 | 14.82M |
| June 30, 2023 | 15.79M |
| March 31, 2023 | 16.92M |
| December 31, 2022 | 15.64M |
| September 30, 2022 | 17.66M |
| June 30, 2022 | 16.09M |
| March 31, 2022 | 13.41M |
| December 31, 2021 | 11.51M |
| September 30, 2021 | 12.24M |
| June 30, 2021 | 11.43M |
| March 31, 2021 | 11.87M |
| December 31, 2020 | 12.34M |
| September 30, 2020 | 8.813M |
| June 30, 2020 | 9.342M |
| March 31, 2020 | 9.464M |
| December 31, 2019 | 9.148M |
| September 30, 2019 | 8.597M |
| Date | Value |
|---|---|
| June 30, 2019 | 8.317M |
| March 31, 2019 | 6.330M |
| December 31, 2018 | 8.070M |
| September 30, 2018 | 6.563M |
| June 30, 2018 | 5.300M |
| March 31, 2018 | 4.712M |
| December 31, 2017 | 2.132M |
| September 30, 2017 | 2.936M |
| June 30, 2017 | 4.385M |
| March 31, 2017 | 4.575M |
| December 31, 2016 | 3.515M |
| September 30, 2016 | 2.933M |
| June 30, 2016 | 1.632M |
| March 31, 2016 | 1.666M |
| December 31, 2015 | 2.149M |
| September 30, 2015 | 1.797M |
| June 30, 2015 | 1.175M |
| March 31, 2015 | 0.7594M |
| December 31, 2014 | 0.9145M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.813M
Minimum
Sep 2020
17.66M
Maximum
Sep 2022
12.91M
Average
12.34M
Median
Dec 2020
Research and Development Expense (TTM) Benchmarks
| Agilent Technologies Inc | 482.00M |
| Seelos Therapeutics Inc | 20.43M |
| Cara Therapeutics Inc | 85.14M |
| Moleculin Biotech Inc | 18.25M |
| Citius Oncology Inc | -- |